121 related articles for article (PubMed ID: 24511039)
1. High UBCH10 protein expression as a marker of poor prognosis in esophageal squamous cell carcinoma.
Matsumoto A; Ishibashi Y; Urashima M; Omura N; Nakada K; Nishikawa K; Shida A; Takada K; Kashiwagi H; Yanaga K
Anticancer Res; 2014 Feb; 34(2):955-61. PubMed ID: 24511039
[TBL] [Abstract][Full Text] [Related]
2. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of the ubiquitin-conjugating enzyme UbcH10 in lung cancer: a useful tool for diagnosis and therapy.
Perrotta I; Bruno L; Maltese L; Russo E; Donato A; Donato G
J Histochem Cytochem; 2012 May; 60(5):359-65. PubMed ID: 22388643
[TBL] [Abstract][Full Text] [Related]
4. Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma.
Li H; Yang C; Chen K; Sun M
Pathol Oncol Res; 2023; 29():1611081. PubMed ID: 37168048
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of gamma-glutamyltransferase in patients with resectable esophageal squamous cell carcinoma.
Yang F; Zhang S; Yang H; Luo K; Wen J; Hu Y; Hu R; Huang Q; Chen J; Fu J
Dis Esophagus; 2015 Jul; 28(5):496-504. PubMed ID: 24766310
[TBL] [Abstract][Full Text] [Related]
7. High endothelin-converting enzyme-1 expression independently predicts poor survival of patients with esophageal squamous cell carcinoma.
Wu CF; Lee CT; Kuo YH; Chen TH; Chang CY; Chang IW; Wang WL
Tumour Biol; 2017 Sep; 39(9):1010428317725922. PubMed ID: 28945168
[TBL] [Abstract][Full Text] [Related]
8. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma.
Ishibashi Y; Matsumoto T; Niwa M; Suzuki Y; Omura N; Hanyu N; Nakada K; Yanaga K; Yamada K; Ohkawa K; Kawakami M; Urashima M
Cancer; 2004 Nov; 101(9):1994-2000. PubMed ID: 15372476
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of CDH1 or CTNNB1 affects poor prognosis of patients with esophageal cancer.
Ishiguro H; Wakasugi T; Terashita Y; Sakamoto N; Tanaka T; Mizoguchi K; Sagawa H; Okubo T; Takeyama H
World J Surg Oncol; 2016 Sep; 14(1):240. PubMed ID: 27600761
[TBL] [Abstract][Full Text] [Related]
10. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
12. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
13. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
15. High expression of LAMP2 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Li L; Wang W; Zhang R; Liu J; Yu J; Wu X; Xu Y; Ma M; Huang J
Cancer Biomark; 2017 Jul; 19(3):305-311. PubMed ID: 28453465
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of
Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
[TBL] [Abstract][Full Text] [Related]
17. KIF-2C expression is correlated with poor prognosis of operable esophageal squamous cell carcinoma male patients.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Fu XY; Ma QL; Wang XY; Lin P
Oncotarget; 2016 Dec; 7(49):80493-80507. PubMed ID: 27563815
[TBL] [Abstract][Full Text] [Related]
18. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.
Saemi N; Khoshnevis J; Akbari ME; Meysamie A; Korourian A; Gholizadeh B; Larijani L; Moradi A; Baikpour M; Baikpour M; Zham H
J Gastrointest Cancer; 2018 Mar; 49(1):35-40. PubMed ID: 27975182
[TBL] [Abstract][Full Text] [Related]
20. High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC.
Yang J; Kong P; Yang J; Jia Z; Hu X; Wang Z; Cui H; Bi Y; Qian Y; Li H; Wang F; Yang B; Yan T; Ma Y; Zhang L; Cheng C; Song B; Li Y; Xu E; Liu H; Gao W; Wang J; Liu Y; Zhai Y; Chang L; Wang Y; Zhang Y; Shi R; Liu J; Wang Q; Cheng X; Cui Y
Technol Cancer Res Treat; 2018 Jan; 17():1533033818781405. PubMed ID: 29950151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]